Drug Name |
Tesamorelin |
Drug ID |
BADD_D02168 |
Description |
Tesamorelin is a stabilized synthetic peptide analogue of the hypothalamic peptide, Growth Hormone Releasing Hormone (GHRH) indicated for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Lipodystrophy is a metabolic condition characterized by insulin resistance, fat redistribution, and hyperlipidemia associated with antiretroviral therapy for HIV infection. |
Indications and Usage |
Tesamorelin acetate is a synthetic analogue of human hypothalamic Growth Hormone Releasing Factor (hGRF) indicated to induce and maintain a reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. |
Marketing Status |
Prescription; Discontinued |
ATC Code |
H01AC06 |
DrugBank ID |
DB08869
|
KEGG ID |
D06655
|
MeSH ID |
C479538
|
PubChem ID |
16137828
|
TTD Drug ID |
D0UL9R
|
NDC Product Code |
76112-711; 62064-241 |
Synonyms |
tesamorelin | TH9507 | TH-9507 | egrifta |